Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_assertion type Assertion NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_head.
- NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_assertion wasGeneratedBy ECO_0000203 NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_provenance.
- NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_assertion wasDerivedFrom befree-20140225 NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_provenance.
- NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_assertion SIO_000772 19780758 NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_provenance.
- NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_assertion evidence source_evidence_literature NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_provenance.
- NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_provenance.